Radient Technologies Inc. Announces Approval and Receipt of Controlled Drugs and Substances Licence from Health Canada

Stock Information for Radient Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Radient Technologies Inc.

Radient Technologies Announces Board Changes
Radient Closes Second and Final Tranche of Financing
Radient Announces Update on Trading Reinstatement
Radient Announces Revocation of Failure-to-File Cease Trade Order
Radient Announces Q3 2023 Financial Results
Radient Technologies Inc. Provides Status Update Regarding Its Interim Financial Statements
IIROC Trading Halt - RTI
Radient Announces Anticipated Issuance of Failure-to-File Cease Trade Order

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.